Netris pancreatic cancer study doses first patient
29th March 2023 Uncategorised 0Company’s candidate NP137 combined with mFOLFIRINOX will be researched during vital trials
More: Netris pancreatic cancer study doses first patient
Source: News
Company’s candidate NP137 combined with mFOLFIRINOX will be researched during vital trials
More: Netris pancreatic cancer study doses first patient
Source: News
© 1994 - 2026 B.M. Pharmaceuticals